Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis-Reference-Cited by-同舟云学术

Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis

Published:1997-01 Issue:1-6 Volume:105 Page:121-130
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:

Author:

VALGARDSDOTTIR RUT,TRYGGVADOTTIR LAUFEY,STEINARSDOTTIR MARGRET,OLAFSDOTTIR KRISTRUN,JONASDOTTIR SIGURROS,JONASSON JON G.,ÖGMUNDSDOTTIR HELGA M.,EYFJÖRD JORUNN E.

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1699-0463.1997.tb00550.x/fullpdf

Reference36 articles.

1. Prognostic significance of TP53 alterations in breast carcinoma;Andersen;Br. J. Cancer,1993

2. Immunohistochemical detection of p53 protein in mammary carcinoma. An important new independent indicator of prognosis;Barnes;Hum. Pathol.,1993

3. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy;Bergh;Nature Med.,1995

4. Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols;Borg;Br. J. Cancer,1995

5. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations;Børresen;Proc. Natl. Acad. Sci. USA (Wash.),1991

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium;Breast Cancer Research;2016-10-03

2. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma;International Journal of Clinical Oncology;2016-08-03

3. Prognostic significance of breast cancer subtype and p53 overexpression in patients with locally advanced or high-risk breast cancer treated using upfront modified radical mastectomy with or without post-mastectomy radiation therapy;International Journal of Clinical Oncology;2011-09-07

4. Clinical Implication of p53 Overexpression in Breast Cancer Patients Younger than 50 Years with a Triple-negative Subtype Who Undergo a Modified Radical Mastectomy;Japanese Journal of Clinical Oncology;2011-06-30

5. Prognostication and Prediction in Anatomic Pathology: Carcinoma of the Breast as an Illustrative Model;Evidence Based Pathology and Laboratory Medicine;2011